Madison Avenue Partners Takes a 5.1% Stake in WLY
October 1, 2024
Viking Global Investors filed an initial 13G for BioMarin Pharmaceutical $BMRN, revealing an ownership stake of 5.10%.
The CEO and the COO of Viridian Therapeutics $VRDN both filed Form 4s revealing purchases of their own stock.
The stock has been in the base-building process for over two years as buyers try to take control and force an upside resolution from this rounding bottom formation:
A breakout above the 49 level would put WLY on a fresh up leg for the foreseeable future.
Stay tuned. We'll be back on Wednesday with more insider activity.
And please reach out with any questions. We love hearing from you!
For questions about your membership, contact us at 323-421-7910 or info@stockmarketmedia.com
